Research Program - Melanoma Therapeutics Program

The Melanoma Therapeutics Program focuses on malignant melanoma, which is the most deadliest form of skin cancer.  The central goal of his program is to unravel the biology and signaling pathways involved in melanoma tumor development in order to develop the next generation of therapeutic agents to treat this disease.  Specifically, it involves identification and validation of novel therapeutic targets, discovery & development of new treatments and clinical evaluation of these experimental drugs in patients.

melanoma

The central goal of his program is to unravel the biology and signaling pathways involved in melanoma tumor development in order to develop the next generation of therapeutic agents to treat this disease.

Specifically, it involves identification and validation of novel therapeutic targets, discovery & development of new treatments